Abbott Laboratories (ABT)
Market Closed
13 Mar, 20:00
$
129. 84
-0.44
-0.34%
$
206.31B Market Cap
36.49 P/E Ratio
2.2% Div Yield
197,766 Volume
4.44 Eps
$ 130.28
Previous Close Day Range
129.1 130.8
Year Range
99.71 141.23
Earnings results expected in 32 days
Summary
ABT closed today lower at $129.84, a decrease of 0.34% from yesterday's close, completing a monthly increase of 14.21% or $16.15. Over the past 12 months, ABT stock gained 9.34%.
ABT pays dividends to its shareholders, with the most recent payment made on Feb 14, 2025. The next announced payment will be in In 2 months on May 15, 2025 for a total of $0.59.
The last earnings report, released on Jan 22, 2025, missed the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0.02%, based on the last three reports. The next scheduled earnings report is due on Apr 15, 2025.
The stock of the company had never split.
The company's stock is traded on 15 different exchanges and in various currencies, with the primary listing on NYSE (USD).
Want to track ABT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
ABT Chart
Abbott Laboratories Dividends
| ABT In 4 months Estimated | Quarterly | $0.59 Per Share |
| ABT In 1 month Announced | Quarterly | $0.59 Per Share |
| ABT 1 month ago Paid | Quarterly | $0.59 Per Share |
| ABT 4 months ago Paid | Quarterly | $0.55 Per Share |
| ABT 7 months ago Paid | Quarterly | $0.55 Per Share |
| ABT 11 months ago Paid | Quarterly | $0.55 Per Share |
Abbott Laboratories Earnings
| 15 Apr 2025 (32 Days) Date | | - Cons. EPS | - EPS |
| 22 Jan 2025 Date | | 1.34 Cons. EPS | 1.34 EPS |
| 16 Oct 2024 Date | | 1.2 Cons. EPS | 1.21 EPS |
| 18 Jul 2024 Date | | 1.1 Cons. EPS | 1.14 EPS |
| 26 Apr 2024 Date | | 0.95 Cons. EPS | 0.98 EPS |
| ABT In 4 months Estimated | Quarterly | $0.59 Per Share |
| ABT In 1 month Announced | Quarterly | $0.59 Per Share |
| ABT 1 month ago Paid | Quarterly | $0.59 Per Share |
| ABT 4 months ago Paid | Quarterly | $0.55 Per Share |
| ABT 7 months ago Paid | Quarterly | $0.55 Per Share |
| ABT 11 months ago Paid | Quarterly | $0.55 Per Share |
| 15 Apr 2025 (32 Days) Date | | - Cons. EPS | - EPS |
| 22 Jan 2025 Date | | 1.34 Cons. EPS | 1.34 EPS |
| 16 Oct 2024 Date | | 1.2 Cons. EPS | 1.21 EPS |
| 18 Jul 2024 Date | | 1.1 Cons. EPS | 1.14 EPS |
| 26 Apr 2024 Date | | 0.95 Cons. EPS | 0.98 EPS |
Abbott Laboratories (ABT) FAQ
What is the stock price today?
The current price is $129.84.
On which exchange is it traded?
Abbott Laboratories is listed on NYSE.
What is its stock symbol?
The ticker symbol is ABT.
Does it pay dividends? What is the current yield?
It does not pay dividends to its shareholders.
What is its market cap?
As of today, the market cap is 206.31B.
What is the earnings per share?
The EPS is 0.
When is the next earnings date?
The next earnings report will release on Apr 15, 2025.
Has Abbott Laboratories ever had a stock split?
No, there has never been a stock split.
Abbott Laboratories Profile
| Medical Devices Industry | Healthcare Sector | Mr. Robert B. Ford CEO | NYSE Exchange | US0028241000 ISIN |
| United States Country | 114,000 Employees | 15 Apr 2025 Last Dividend | 2 Jan 2013 Last Split | 13 Jan 1978 IPO Date |
Overview
Abbott Laboratories is a global healthcare company that engages in the discovery, development, manufacturing, and sale of a wide range of health care products. With its foundation laid in 1888, and headquartered in North Chicago, Illinois, the company has established a significant presence worldwide. Abbott operates across four main sectors: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices, catering to a diverse range of healthcare needs from generic pharmaceuticals to advanced medical devices.
Products and Services
Abbott Laboratories offers a comprehensive portfolio of products and services across various healthcare domains:
- Generic Pharmaceuticals: Includes treatments for pancreatic exocrine insufficiency, irritable bowel syndrome, biliary spasm, intrahepatic cholestasis, depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease, vestibular vertigo, pain, fever, inflammation, migraine, anti-infective clarithromycin, influenza vaccine, and colon rhythm regulation products.
- Diagnostic Products: Offers laboratory and transfusion medicine systems in areas such as immunoassay, clinical chemistry, hematology, and transfusion. Includes molecular diagnostics for DNA and RNA processing and detection of infectious agents, point-of-care systems, blood gas testing cartridges, rapid diagnostics, molecular point-of-care testing for several diseases, cardiometabolic tests, drug and alcohol tests, remote patient monitoring, consumer self-tests, and laboratory automation and informatics solutions.
- Nutritional Products: Provides nutritional products for both pediatric and adult use, catering to the specific dietary needs of different age groups and health conditions.
- Medical Devices: Offers a wide array of devices for the treatment of cardiovascular diseases, including rhythm management, electrophysiology, heart failure, vascular, and structural heart devices. Additionally, the company develops diabetes care products such as blood glucose monitoring systems, along with neuromodulation devices for managing chronic pain and movement disorders.
Contact Information
Address: 100 Abbott Park Road
Phone: 224 667 6100
Website: https://www.abbott.com
2025 © Marketlog. All Rights Reserved.
